Inverness commences Biosite offer:
This article was originally published in Clinica
Executive Summary
Inverness Medical Innovations has announced that its subsidiary Inca Acquisition has begun its cash tender offer for shares of diagnostic test developer Biosite at $92.50 per share. The Biosite board of directors has approved the offer and has judged it to be fair and in the shareholders' best interests. The company was originally the focus of a bidding war between Beckman Coulter and Inverness, however the Waltham, Massachusetts-based company trumped Beckman's final offer of $90 per share two weeks ago (see Clinica No 1256, p 2).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.